DB
MDXG icon

Dmitry Balyasny’s MiMedx Group MDXG Stock Holding History

Dmitry Balyasny’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,648,100
Closed -$9.06M – 1600
2018
Q3 		$9.06M Buy
1,648,100
+131,900
+9% +$596K 0.04% 522
2018
Q2 		$9.69M Buy
1,516,200
+1,185,200
+358% +$8.44M 0.04% 499
2018
Q1 		$2.31M Sell
331,000
-1,301,900
-80% -$15.2M 0.01% 955
2017
Q4 		$20.6M Buy
1,632,900
+597,900
+58% +$7.29M 0.06% 397
2017
Q3 		$12.3M Buy
1,035,000
+443,700
+75% +$6.58M 0.05% 436
2017
Q2 		$8.85M Buy
+591,300
New +$7.89M 0.04% 572

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dmitry Balyasny's MDXG Position: Q1 2026 in Review

Dmitry Balyasny sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 40,015 shares — an estimated $271K sold.

Dmitry Balyasny first reported a position in MDXG in Q3 2015 and held it in 13 quarters. The position peaked at $22.4M in Q4 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Dmitry Balyasny reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 40,015 MiMedx Group shares in Q1 2026, an estimated $271K.
  • Dmitry Balyasny first reported a position in MiMedx Group in Q3 2015 and held it in 13 quarters.
  • Dmitry Balyasny's MiMedx Group position peaked at $22.4M in Q4 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.